Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | podophyllotoxin | 30699 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | podophyllotoxin | 30699 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | podophyllotoxin | 30699 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | podophyllotoxin | 30699 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | podophyllotoxin | 30699 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | podophyllotoxin | 30699 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | podophyllotoxin | 30699 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | paroxetine | 43815 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | paroxetine | 43815 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | paroxetine | 43815 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | pheneticillin | 272833 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | pheneticillin | 272833 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | pheneticillin | 272833 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | pheneticillin | 272833 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | pheneticillin | 272833 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | pheneticillin | 272833 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | pheneticillin | 272833 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | pheneticillin | 272833 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | pheneticillin | 272833 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | pheneticillin | 272833 | drug-path |